iRhythm Holdings, Inc. — Form 8-K
Filed August 6, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 68/100
What the filing says
iRhythm announced a definitive agreement to acquire privately held VitalConnect for approximately $287.5M ($237.5M cash from balance sheet, $50M stock). The acquisition adds mobile cardiac telemetry, multi-vitals monitoring, and hospital-to-home care capabilities. Q2 2026 revenue grew 20.1% to $224.2M; adjusted EBITDA margin improved 1,090 bps to 19.3%; FY2026 guidance raised to $880–$890M revenue with 13.0–14.0% adjusted EBITDA margin. Transaction expected to close by end of 2026.
Why this rating
Material acquisition (~6% of market cap) with strategic and operational benefits; strong Q2 beats, margin expansion, and raised guidance support positive near-term momentum and growth trajectory.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.